Enhancing mRNA therapy through iterative delivery

Area of Science:

• Biotechnology
• Nanomedicine
• Oncology

Background:

• Clinical translation of therapeutic messenger RNA (mRNA) for solid tumors is hindered by inadequate delivery systems.
• Effective delivery is crucial for enhancing mRNA's therapeutic potential in cancer treatment.

Purpose of the Study:

• To develop and evaluate a novel mRNA delivery system for improved efficacy in solid tumors.
• To investigate the mechanisms underlying the enhanced delivery and therapeutic effects of the novel system.

Main Methods:

• Co-encapsulation of gold nanoparticles (AuNPs) and mRNA within non-ionic surfactant vehicles (NSVs) to create "Aurniosomes" (AuNSVs).
• In vitro and in vivo studies to assess vector accumulation, cellular uptake, protein expression, and therapeutic efficacy.
• Mechanistic studies involving clathrin-mediated endocytosis (CME), caveolin-mediated endocytosis (CvME), and endolysosomal trafficking pathways.

Main Results:

• AuNSVs demonstrated improved accumulation and uptake within tumors compared to conventional systems.
• Enhanced protein expression and significant therapeutic efficacy were observed in both in vitro and in vivo models.
• Mechanistic studies revealed an iterative delivery process involving AuNP-mediated inactivation of cellular regulators, promoting further AuNSV entry and endosomal escape.

Conclusions:

• AuNSVs represent a promising next-generation mRNA delivery platform for solid tumors.
• The unique iterative delivery mechanism enhances mRNA bioavailability and therapeutic outcomes.
• This approach holds potential for advancing mRNA-based cancer therapies.